{"id":25395,"date":"2023-04-04T11:22:55","date_gmt":"2023-04-04T10:22:55","guid":{"rendered":"https:\/\/www.intelligentcio.com\/apac\/?p=25395"},"modified":"2023-05-25T11:39:12","modified_gmt":"2023-05-25T10:39:12","slug":"rackspace-technology-and-inphronesis-modernize-email-infrastructure-and-optimize-knowledge-management-portal","status":"publish","type":"post","link":"https:\/\/www.intelligentcio.com\/apac\/2023\/04\/04\/rackspace-technology-and-inphronesis-modernize-email-infrastructure-and-optimize-knowledge-management-portal\/","title":{"rendered":"Rackspace Technology and inPhronesis modernize email infrastructure and optimize knowledge management portal"},"content":{"rendered":"\n<p>Rackspace Technology, a leading end-to-end multi-cloud technology solutions company, has announced working with&nbsp;inPhronesis, a biomedical software company,&nbsp;to modernize the company\u2019s email infrastructure and optimize the knowledge management portal. The biomedical software expert manages the data and intelligence that drives the management of pharmaceutical companies with Microsoft 365.<\/p>\n\n\n\n<p>inPhronesis was designed by competitive intelligence (CI) consultants to track large amounts of ever-changing data for competitive and business intelligence (BI) inside the pharma and biomedical industries. The company\u2019s mission is to offer clients a streamlined interface with custom functionality for their business intelligence. The software development company was founded in 2019 in Orlando, Florida, to allow users to configure enterprise-level solutions that make their customers\u2019 lives easier.<\/p>\n\n\n\n<p>inPhronesis\u2019 main product, inVision, is software that delivers essential insights into the biomedical industry. The application is a hub of client information used by over 3,500 pharmaceutical and medical technology professionals to stay up to date on the industry. The system sends out multiple daily alerts reporting on different markets, classes of drugs and advancements at various companies.<\/p>\n\n\n\n<p>Rackspace Technology was tasked with helping the inPhronesis IT team map out a plan for integrating dozens of different applications and tools and account for managing mobile Windows, iOS and Android devices used by employees in the field.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rackspace Technology, a leading end-to-end multi-cloud technology solutions company, has announced working with&nbsp;inPhronesis, a biomedical software company,&nbsp;to modernize the company\u2019s email infrastructure and optimize the knowledge management portal. The biomedical software expert manages the data and intelligence that drives the management of pharmaceutical companies with Microsoft 365. inPhronesis was designed by competitive intelligence (CI) consultants [&hellip;]<\/p>\n","protected":false},"author":50,"featured_media":25396,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12,51,40,44,54],"tags":[4313,79,4312,4314,4311,646,91],"class_list":["post-25395","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-intelligent-technologies-cloud","category-intelligent-technology-newsletter","category-software","category-top-stories","category-used","tag-biomedical","tag-cloud","tag-email-infrastructure","tag-inphronesis","tag-knowledge-management","tag-rackspace-technology","tag-software"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/posts\/25395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/users\/50"}],"replies":[{"embeddable":true,"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/comments?post=25395"}],"version-history":[{"count":7,"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/posts\/25395\/revisions"}],"predecessor-version":[{"id":25765,"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/posts\/25395\/revisions\/25765"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/media\/25396"}],"wp:attachment":[{"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/media?parent=25395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/categories?post=25395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.intelligentcio.com\/apac\/wp-json\/wp\/v2\/tags?post=25395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}